Entities / Technology
JMP.
suite of computer programs for statistical analysis developed by JMP Statistical Discovery LLC
- Reports this week
- 0
- Active events
- 0
- Connections
- 10
What's happening
Reports per dayLast 90 days
90 days agoDrag either end to show only events that began in that periodToday
One to three months ago
Gone quiet
No new reports in 90+ days-
JMP maintained a Market Outperform rating on Whitestone REIT, noting its portfolio includes high-growth Texas markets.Speculative1 report
-
Zscaler, headquartered in San Jose, benefits from Trump-era tariffs, while JMP raises price targets amid strong growth.Some support2 reports
-
JMP reaffirmed a Market Outperform rating and price target for Evolent Health, Inc. on July 4, 2025.Speculative1 report
No events began in the chosen period. Widen it, or reset.
Around JMP this week
News at the entities that move JMP most-
Salesforce Mentioned togetherFisher & Paykel discussed AI strategy at a Salesforce conference, reflecting broader shifts in New Zealand enterprises.Moves JMP
-
Peng Mentioned togetherBillionaires attended a state dinner at Joint Base Andrews honoring Peng, amidst geopolitical conflict.Moves JMP
Connections
The 3 strongest of 10, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Salesforce Mentioned together
JMP provides financial analysis and reviews of Salesforce's technologies and valuation.
-
Philip Kay Mentioned together
Philip Kay cited JMP as an example of analytical software in discussions about analytical science.
-
Peng Mentioned together
JMP analysts raised price targets for Penguin Solutions, linking the two entities through financial commentary.
History
Events by the month they beganJuly 2026
1 eventJune 2026
3 events- JMP maintained a Market Outperform rating on Whitestone REIT, noting its portfolio includes high-growth Texas markets.
- Zscaler, headquartered in San Jose, benefits from Trump-era tariffs, while JMP raises price targets amid strong growth.
- JMP reaffirmed a Market Outperform rating and price target for Evolent Health, Inc. on July 4, 2025.